Cincinnati, OH, United States of America

Michael Auld

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Auld - Innovator in Ocular Technology

Introduction

Michael Auld is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of ocular technology, particularly with his innovative patent that addresses a critical need in eye surgery.

Latest Patents

Michael Auld holds a patent for an ocular cannula guide. This apparatus includes a body, an anchoring feature, and a guide feature. The body is designed to be positioned on the eye of a patient. The anchoring feature secures the body to the eye, while the guide feature directs a cannula into a scleral incision along a path that is substantially tangential to the eye. This design allows the cannula to pivot laterally through a range of angular motion at the incision site, enhancing the precision of ocular procedures. He has 1 patent to his name.

Career Highlights

Michael Auld is currently employed at Genentech, Inc., where he continues to develop innovative solutions in the medical field. His work focuses on improving surgical techniques and patient outcomes through advanced technology.

Collaborations

Some of his coworkers include Thomas E Meyer and Mark Hedgeland, who contribute to the collaborative environment at Genentech, Inc. Their combined expertise fosters innovation and drives the development of new medical technologies.

Conclusion

Michael Auld's contributions to ocular technology through his patent for an ocular cannula guide exemplify his commitment to advancing medical procedures. His work at Genentech, Inc. continues to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…